The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Hospital acquired infections/diseases (HAIs) or nosocomial infections are defined to the infection acquired by patients during their stay in healthcare settings. Approximately 9.2 out of 100 patients in the U.S. acquire HAI. The most common types of HAIs include pneumonia, urinary tract infection, bloodstream infection, surgical site infection and others. HAIs are caused by pathogens among patients with compromised immune system, and negligence by hospital staff. The significant morbidity and mortality, the associated management costs and growing pressure from governing bodies have urged care-givers to devise accurate diagnosis of HAIs for efficient healthcare provision.
The global Hospital-Acquired Disease Testing market was valued at US$ 492.3 million in 2023 and is anticipated to reach US$ 706.1 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hospital-Acquired Disease Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital-Acquired Disease Testing.
Report Scope
The Hospital-Acquired Disease Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hospital-Acquired Disease Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hospital-Acquired Disease Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company(Partial List)
- Diatherix Laboratories
- Gen-Probe
- Qiagen
- F. Hoffmann-La Roche
- Cepheid
- Life Technologies Corporation
- Meridian Biosciences
- Cantel Medical Corporation
- Nordion
Segment by Type
- UTI Testing
- SSI Testing
- Pneumococcal Infections Testing
- Bloodstream Infections Testing
- MRSA Testing
Segment by Application
- Small and Medium Sized Hospitals
- Large Sized Hospitals
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hospital-Acquired Disease Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital-Acquired Disease Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 UTI Testing
1.2.3 SSI Testing
1.2.4 Pneumococcal Infections Testing
1.2.5 Bloodstream Infections Testing
1.2.6 MRSA Testing
1.3 Market by Application
1.3.1 Global Hospital-Acquired Disease Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Small and Medium Sized Hospitals
1.3.3 Large Sized Hospitals
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hospital-Acquired Disease Testing Market Perspective (2019-2030)
2.2 Hospital-Acquired Disease Testing Growth Trends by Region
2.2.1 Global Hospital-Acquired Disease Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hospital-Acquired Disease Testing Historic Market Size by Region (2019-2024)
2.2.3 Hospital-Acquired Disease Testing Forecasted Market Size by Region (2025-2030)
2.3 Hospital-Acquired Disease Testing Market Dynamics
2.3.1 Hospital-Acquired Disease Testing Industry Trends
2.3.2 Hospital-Acquired Disease Testing Market Drivers
2.3.3 Hospital-Acquired Disease Testing Market Challenges
2.3.4 Hospital-Acquired Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital-Acquired Disease Testing Players by Revenue
3.1.1 Global Top Hospital-Acquired Disease Testing Players by Revenue (2019-2024)
3.1.2 Global Hospital-Acquired Disease Testing Revenue Market Share by Players (2019-2024)
3.2 Global Hospital-Acquired Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hospital-Acquired Disease Testing Revenue
3.4 Global Hospital-Acquired Disease Testing Market Concentration Ratio
3.4.1 Global Hospital-Acquired Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital-Acquired Disease Testing Revenue in 2023
3.5 Hospital-Acquired Disease Testing Key Players Head office and Area Served
3.6 Key Players Hospital-Acquired Disease Testing Product Solution and Service
3.7 Date of Enter into Hospital-Acquired Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital-Acquired Disease Testing Breakdown Data by Type
4.1 Global Hospital-Acquired Disease Testing Historic Market Size by Type (2019-2024)
4.2 Global Hospital-Acquired Disease Testing Forecasted Market Size by Type (2025-2030)
5 Hospital-Acquired Disease Testing Breakdown Data by Application
5.1 Global Hospital-Acquired Disease Testing Historic Market Size by Application (2019-2024)
5.2 Global Hospital-Acquired Disease Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hospital-Acquired Disease Testing Market Size (2019-2030)
6.2 North America Hospital-Acquired Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hospital-Acquired Disease Testing Market Size by Country (2019-2024)
6.4 North America Hospital-Acquired Disease Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hospital-Acquired Disease Testing Market Size (2019-2030)
7.2 Europe Hospital-Acquired Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hospital-Acquired Disease Testing Market Size by Country (2019-2024)
7.4 Europe Hospital-Acquired Disease Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hospital-Acquired Disease Testing Market Size (2019-2030)
8.2 Asia-Pacific Hospital-Acquired Disease Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hospital-Acquired Disease Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Hospital-Acquired Disease Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hospital-Acquired Disease Testing Market Size (2019-2030)
9.2 Latin America Hospital-Acquired Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hospital-Acquired Disease Testing Market Size by Country (2019-2024)
9.4 Latin America Hospital-Acquired Disease Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital-Acquired Disease Testing Market Size (2019-2030)
10.2 Middle East & Africa Hospital-Acquired Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hospital-Acquired Disease Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Hospital-Acquired Disease Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Diatherix Laboratories
11.1.1 Diatherix Laboratories Company Detail
11.1.2 Diatherix Laboratories Business Overview
11.1.3 Diatherix Laboratories Hospital-Acquired Disease Testing Introduction
11.1.4 Diatherix Laboratories Revenue in Hospital-Acquired Disease Testing Business (2019-2024)
11.1.5 Diatherix Laboratories Recent Development
11.2 Gen-Probe
11.2.1 Gen-Probe Company Detail
11.2.2 Gen-Probe Business Overview
11.2.3 Gen-Probe Hospital-Acquired Disease Testing Introduction
11.2.4 Gen-Probe Revenue in Hospital-Acquired Disease Testing Business (2019-2024)
11.2.5 Gen-Probe Recent Development
11.3 Qiagen
11.3.1 Qiagen Company Detail
11.3.2 Qiagen Business Overview
11.3.3 Qiagen Hospital-Acquired Disease Testing Introduction
11.3.4 Qiagen Revenue in Hospital-Acquired Disease Testing Business (2019-2024)
11.3.5 Qiagen Recent Development
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Detail
11.4.2 F. Hoffmann-La Roche Business Overview
11.4.3 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Introduction
11.4.4 F. Hoffmann-La Roche Revenue in Hospital-Acquired Disease Testing Business (2019-2024)
11.4.5 F. Hoffmann-La Roche Recent Development
11.5 Cepheid
11.5.1 Cepheid Company Detail
11.5.2 Cepheid Business Overview
11.5.3 Cepheid Hospital-Acquired Disease Testing Introduction
11.5.4 Cepheid Revenue in Hospital-Acquired Disease Testing Business (2019-2024)
11.5.5 Cepheid Recent Development
11.6 Life Technologies Corporation
11.6.1 Life Technologies Corporation Company Detail
11.6.2 Life Technologies Corporation Business Overview
11.6.3 Life Technologies Corporation Hospital-Acquired Disease Testing Introduction
11.6.4 Life Technologies Corporation Revenue in Hospital-Acquired Disease Testing Business (2019-2024)
11.6.5 Life Technologies Corporation Recent Development
11.7 Meridian Biosciences
11.7.1 Meridian Biosciences Company Detail
11.7.2 Meridian Biosciences Business Overview
11.7.3 Meridian Biosciences Hospital-Acquired Disease Testing Introduction
11.7.4 Meridian Biosciences Revenue in Hospital-Acquired Disease Testing Business (2019-2024)
11.7.5 Meridian Biosciences Recent Development
11.8 Cantel Medical Corporation
11.8.1 Cantel Medical Corporation Company Detail
11.8.2 Cantel Medical Corporation Business Overview
11.8.3 Cantel Medical Corporation Hospital-Acquired Disease Testing Introduction
11.8.4 Cantel Medical Corporation Revenue in Hospital-Acquired Disease Testing Business (2019-2024)
11.8.5 Cantel Medical Corporation Recent Development
11.9 Nordion
11.9.1 Nordion Company Detail
11.9.2 Nordion Business Overview
11.9.3 Nordion Hospital-Acquired Disease Testing Introduction
11.9.4 Nordion Revenue in Hospital-Acquired Disease Testing Business (2019-2024)
11.9.5 Nordion Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
